Literature DB >> 20844971

Self-efficacy contributes to individual differences in subjective improvements using CPAP.

Kelly Glazer Baron1, Cynthia A Berg, Laura A Czajkowski, Timothy W Smith, Heather E Gunn, Christopher R Jones.   

Abstract

PURPOSE: Continuous positive airway pressure (CPAP) improves depressive symptoms and daytime sleepiness in patients with obstructive sleep apnea (OSA). However, there is variability in response to CPAP. This study examined individual differences in the daily associations between CPAP use and improvements in affect and sleepiness patients beginning CPAP.
METHODS: This observational repeated measures study involved 31 CPAP-naïve patients diagnosed with obstructive sleep apnea at an academic sleep disorders center. Patients completed pre-treatment assessments of OSA knowledge, expectations for CPAP, and treatment self-efficacy as well as a repeated daily assessment of positive affect and negative affect, sleepiness/fatigue, and CPAP adherence for 10 days beginning the first week of treatment. Data were analyzed using multilevel modeling.
RESULTS: Nightly CPAP adherence predicted improvements in next-day positive affect, negative affect, and sleepiness/fatigue. The apnea-hypopnea index (AHI), treatment self-efficacy, and outcome expectancies were significant moderators of day-to-day improvement. Higher self-efficacy and lower AHI were associated with a stronger relationship between adherence and next-day improvements in positive affect and sleepiness. Very high-outcome expectances were associated with a weaker relationship between adherence and next-day improvements in sleepiness. Subjective sleepiness at pre-treatment did not give moderate improvements in next-day affect.
CONCLUSIONS: Although CPAP use predicted daily improvements in affect and sleepiness for the majority of patients, patients with lower AHI, greater treatment self-efficacy, and moderate outcome expectancies reported stronger daily benefits from CPAP. For patients with high-treatment efficacy, adherence may be reinforced by a stronger link between adherence and daily improvements.

Entities:  

Mesh:

Year:  2010        PMID: 20844971     DOI: 10.1007/s11325-010-0409-5

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  33 in total

1.  Improving compliance with nasal CPAP and vigilance in older adults with OAHS.

Authors:  M S Aloia; L Di Dio; N Ilniczky; M L Perlis; D W Greenblatt; D E Giles
Journal:  Sleep Breath       Date:  2001       Impact factor: 2.816

2.  Proposed supplements and amendments to 'A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects', the Rechtschaffen & Kales (1968) standard.

Authors:  T Hori; Y Sugita; E Koga; S Shirakawa; K Inoue; S Uchida; H Kuwahara; M Kousaka; T Kobayashi; Y Tsuji; M Terashima; K Fukuda; N Fukuda
Journal:  Psychiatry Clin Neurosci       Date:  2001-06       Impact factor: 5.188

3.  Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea: results of a meta-analysis.

Authors:  Sanjay R Patel; David P White; Atul Malhotra; Michael L Stanchina; Najib T Ayas
Journal:  Arch Intern Med       Date:  2003-03-10

4.  Determinants of continuous positive airway pressure compliance in a group of Chinese patients with obstructive sleep apnea.

Authors:  D S Hui; D K Choy; T S Li; F W Ko; K K Wong; J K Chan; C K Lai
Journal:  Chest       Date:  2001-07       Impact factor: 9.410

5.  Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study.

Authors:  Jose M Marin; Santiago J Carrizo; Eugenio Vicente; Alvar G N Agusti
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

6.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale.

Authors:  M W Johns
Journal:  Sleep       Date:  1991-12       Impact factor: 5.849

7.  Self-efficacy in sleep apnea: instrument development and patient perceptions of obstructive sleep apnea risk, treatment benefit, and volition to use continuous positive airway pressure.

Authors:  Terri E Weaver; Greg Maislin; David F Dinges; Joel Younger; Charles Cantor; Susan McCloskey; Allan I Pack
Journal:  Sleep       Date:  2003-09       Impact factor: 5.849

8.  Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning.

Authors:  Terri E Weaver; Greg Maislin; David F Dinges; Thomas Bloxham; Charles F P George; Harly Greenberg; Gihan Kader; Mark Mahowald; Joel Younger; Allan I Pack
Journal:  Sleep       Date:  2007-06       Impact factor: 5.849

9.  A self-management approach to improving continuous positive airway pressure adherence and outcomes.

Authors:  Carl J Stepnowsky; Joe J Palau; Allen L Gifford; Sonia Ancoli-Israel
Journal:  Behav Sleep Med       Date:  2007       Impact factor: 2.964

10.  Early CPAP use identifies subsequent adherence to CPAP therapy.

Authors:  Rohit Budhiraja; Sairam Parthasarathy; Christopher L Drake; Thomas Roth; Imran Sharief; Pooja Budhiraja; Victoria Saunders; David W Hudgel
Journal:  Sleep       Date:  2007-03       Impact factor: 5.849

View more
  13 in total

Review 1.  Patient-centered care in obstructive sleep apnea: A vision for the future.

Authors:  Janet Hilbert; Henry K Yaggi
Journal:  Sleep Med Rev       Date:  2017-02-24       Impact factor: 11.609

2.  Increasing adherence to obstructive sleep apnea treatment with a group social cognitive therapy treatment intervention: a randomized trial.

Authors:  Delwyn Bartlett; Keith Wong; Dianne Richards; Emma Moy; Colin A Espie; Peter A Cistulli; Ronald Grunstein
Journal:  Sleep       Date:  2013-11-01       Impact factor: 5.849

Review 3.  A systematic review of CPAP adherence across age groups: clinical and empiric insights for developing CPAP adherence interventions.

Authors:  Amy M Sawyer; Nalaka S Gooneratne; Carole L Marcus; Dafna Ofer; Kathy C Richards; Terri E Weaver
Journal:  Sleep Med Rev       Date:  2011-06-08       Impact factor: 11.609

4.  Adherence to Continuous Positive Airway Pressure in Existing Users: Self-Efficacy Enhances the Association between Continuous Positive Airway Pressure and Adherence.

Authors:  Joseph M Dzierzewski; Douglas M Wallace; William K Wohlgemuth
Journal:  J Clin Sleep Med       Date:  2016-02       Impact factor: 4.062

5.  Determinants of continuous positive airway pressure adherence in a sleep clinic cohort of South Florida Hispanic veterans.

Authors:  D M Wallace; S S Vargas; S J Schwartz; M S Aloia; S Shafazand
Journal:  Sleep Breath       Date:  2012-04-17       Impact factor: 2.816

6.  A new characterization of adherence patterns to auto-adjusting positive airway pressure in severe obstructive sleep apnea syndrome: clinical and psychological determinants.

Authors:  Rute Sampaio; M Graça Pereira; João C Winck
Journal:  Sleep Breath       Date:  2013-02-06       Impact factor: 2.816

7.  Willingness score obtained after a short CPAP trial predicts CPAP use at 1 year.

Authors:  Hanna-Riikka Kreivi; Paula Maasilta; Adel Bachour
Journal:  Sleep Breath       Date:  2013-06-28       Impact factor: 2.816

8.  Risk assessment for CPAP nonadherence in adults with newly diagnosed obstructive sleep apnea: preliminary testing of the Index for Nonadherence to PAP (I-NAP).

Authors:  Amy M Sawyer; Tonya S King; Alexandra Hanlon; Kathy C Richards; Leon Sweer; Albert Rizzo; Terri E Weaver
Journal:  Sleep Breath       Date:  2014-03-05       Impact factor: 2.816

9.  Stage-matched intervention for adherence to CPAP in patients with obstructive sleep apnea: a randomized controlled trial.

Authors:  Ting Deng; Yan Wang; Mei Sun; Baoyuan Chen
Journal:  Sleep Breath       Date:  2012-09-04       Impact factor: 2.816

Review 10.  Personalized and Patient-Centered Strategies to Improve Positive Airway Pressure Adherence in Patients with Obstructive Sleep Apnea.

Authors:  Alexa J Watach; Dennis Hwang; Amy M Sawyer
Journal:  Patient Prefer Adherence       Date:  2021-07-12       Impact factor: 2.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.